In addition, the other effect molecules closely associated with the ERK1/2 signal, including the phosphatase Shp2, which is supposed to be a prospective target for lung cancer therapy [38, 39, 40], showed no significant change upon the Fbxo45 expression (Fig. 3B). The gene discussed is FBXO45; the disease is lung carcinoma.